Tackling TB: Developing the First Novel Drug Regimen

TB drug development has long been a neglected field. However, the recent years have been characterized by a growing momentum, fueled by a restocked pipeline and an exciting new approach to drug development designed to drastically reduce development timelines. Today, the world’s first novel TB regimen is in development, performing well, and charting a path to revolutionize TB treatment. Faster. Simpler. Affordable.